ALLISON MANLEY: Open Payments
NPI 1497305221 · PALOS HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,799 in 254 payments from 23 companies in 2025. Trend: 2023 $4,956 · 2024 $7,147 · 2025 $4,799
Food & beverage: $4,799
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $734 |
| UCB, Inc. | 24 | $565 |
| Incyte Corporation | 18 | $463 |
| Lilly USA, LLC | 21 | $405 |
| Regeneron Healthcare Solutions, Inc. | 12 | $404 |
| Janssen Biotech, Inc. | 22 | $393 |
| Organon LLC | 19 | $355 |
| Novartis Pharmaceuticals Corporation | 20 | $343 |
| E.R. Squibb & Sons, L.L.C. | 27 | $262 |
| PFIZER INC. | 16 | $247 |
Products named: Bimzelx, SKYRIZI, OPZELURA, TREMFYA, DUPIXENT, EBGLYSS, RINVOQ, Sotyktu.
Industry payments across IL — which companies pay providers there.
